NCT00328458 2025-05-02
EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients
Thomas Jefferson University
Phase 1 Completed
Clinical Trials
22 trialsNCT00219297 2021-02-21
Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer
Novartis
Phase 2 Completed
NCT00262990 2020-12-17
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
Novartis
Phase 3 Completed
NCT00420524 2020-12-09
A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
Novartis
Phase 1 Completed
NCT00426582 2020-12-09
Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors
Novartis
Phase 1 Completed
NCT00420615 2020-12-08
Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies
Novartis
Phase 1 Completed
NCT00426140 2020-12-08
Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.
Novartis
Phase 1 Completed
NCT00969046 2020-12-08
Dose-Escalation Study in Advanced Colon Cancer Patients
Novartis
Phase 1 Completed
NCT00159484 2017-06-27
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
University of Southern California
Phase 1/2 Unknown
NCT00050349 2017-03-01
EPO906 in Carcinoid and Other Neuroendocrine Tumors
Novartis
Phase 2 Completed
NCT00035113 2017-02-09
EPO906 Therapy in Patients With Prostate Cancer
Novartis
Phase 2 Completed
NCT00273312 2017-02-07
Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma
Novartis
Phase 2 Completed
NCT00450866 2014-02-28
Epothilone B in Treating Patients With CNS Metastases From Breast Cancer
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00035087 2013-12-04
EPO906 Therapy in Patients With Advanced Colorectal Cancer
Novartis
Phase 2 Completed
NCT00496600 2012-06-14
Phase I Study of Patupilone and RAD001
Rutgers, The State University of New Jersey
Phase 1 Completed
NCT00442741 2012-04-25
Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)
Novartis
Phase 1 Withdrawn
NCT00421044 2012-01-11
A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
Novartis
Phase 1 Completed
NCT00715013 2011-09-15
Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma
University of Zurich
Phase 1/2 Completed
NCT00407251 2010-11-05
Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy
British Columbia Cancer Agency
Phase 2 Completed
NCT00412789 2010-05-31
Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan
Novartis
Phase 1 Completed
NCT00448396 2009-11-19
Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies
Novartis
Phase 1 Completed
NCT00468260 2009-11-19
The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies
Novartis
Phase 1 Terminated